The global electrophysiology device market size was valued at 5.1 billion in 2018. The growing use of electrophysiology devices in the diagnosis and treatment of cardiovascular diseases such as atrial fibrillation, the growing demand for cardiac rhythm management devices for continuous monitoring, and the growing use of these devices in the hospital environment will have a significant impact on rendering the growth drivers of the market. The increase in heart failure (HF) and heart attack cases due to lifestyle habits such as smoking and excessive drinking among millennials are the major factors driving the market.
A full report of Electrophysiology Market available at https://www.orionmarketreports.com/electrophysiology-market-market/3169/
St. Jude Medical, Inc., Biosense Webster, Inc. (a Johnson & Johnson Company), Boston Scientific Corporation, GE Healthcare (a division of General Electric Company.), Siemens AG, Medtronic plc, Philips Healthcare (a division of Koninklijke Philips N.V.), Biotronik SE & Co.KG, Microport Scientific Corporation, and Abbott Laboratories are the key players that operate in this market.
Electrophysiology Market: Segmentation
By Product
• EP Ablation Catheters
• EP Laboratory Devices
• EP Diagnostic Catheters
• Access Devices
• Others
By Indication
• Atrial Fibrillation (AF)
• Atrial Flutter
• Wolff-Parkinson-White Syndrome (WPW)
• Atrioventricular Nodal Reentry Tachycardia (AVNRT)
• Others
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
